Stem cell researcher who sued Harvard, Brigham & Women’s is leaving his post

A stem cell researcher who sued his employers, Harvard and Brigham & Women’s Hospital, is headed to Switzerland. Piero Anversa‘s departure follows the dismissal of his suit last summer. Anversa filed the suit with colleague Annarosa Leri, claiming that an investigation into their work damaged their reputations: they lost a multimillion-dollar offer to purchase their company, Autologous/Progenital; and both … Continue reading Stem cell researcher who sued Harvard, Brigham & Women’s is leaving his post

Yale doc loses 2 HuffPo blog posts after secretly promoting his novel

The Huffington Post has retracted two blog posts by prominent Yale nutritionist David Katz after learning he had posted incredibly favorable reviews of a new novel — and not revealed that he had written the novel himself, under a pseudonym. There’s no doubt Katz is a prolific writer — in addition to a couple hundred scientific articles … Continue reading Yale doc loses 2 HuffPo blog posts after secretly promoting his novel

Weekend reads: The end of journals?; Impact Factor for sale; fake peer reviews earn funding bans

This morning, our thoughts are with the people of Paris. The week at Retraction Watch featured the retraction of a paper claiming dramatically higher rates of sexual trauma among men in the military, and a look at whether gender plays a role in peer review. Also: We’re hiring. Here’s what was happening elsewhere:

After court verdict, BMJ retracts 26-year-old paper

Today, The BMJ retracted a 1989 paper about the role of breastfeeding and formula in infant eczema — 20 years after the data were called into question by a university report. However, the report was kept secret — due, by some accounts, to alleged threats of a lawsuit. That is, until this year, when author Ranjit Kumar … Continue reading After court verdict, BMJ retracts 26-year-old paper

Weekend reads: Academic article brokering; favorite fieldwork bloopers; worst peer review ever

This week, we marked the fifth anniversary of Retraction Watch with the announcement of a generous new grant. We also covered the retraction of a slew of papers in a journal plagued by problems. Here’s what was happening elsewhere:

Nutrition researcher Chandra loses libel case against CBC

The self-proclaimed “father of nutritional immunology,” Ranjit Kumar Chandra, has lost a libel lawsuit against the Canadian Broadcasting Company (CBC). The suit was in response to a 2006 three-part documentary from the CBC, which examined allegations of fraud against the former Memorial University researcher. After the 58-day trial, the Ontario Superior Court of Justice “ruled … Continue reading Nutrition researcher Chandra loses libel case against CBC

Judge dismisses cardiac stem cell researchers’ lawsuit against Harvard

A Massachusetts judge has dismissed a lawsuit by researchers who argued that an investigation by Harvard cost them job offers. Last year, Piero Anversa, a stem cell researcher at the Brigham & Women’s Hospital, and a colleague, Annarosa Leri, sued Harvard over an investigation into their work that they claim damaged their reputations:

Weekend reads: California universities battle in court for research dollars; fake conferences; fake impact factors

This week at Retraction Watch featured a look at the nuances of replication efforts, aka “the replication paradox,” as well as yet another story of fake peer reviews, this time at Hindawi. Here’s what was happening elsewhere:

Macchiarini co-author objects to investigation’s misconduct verdict

One of Paolo Macchiarini’s co-authors on a 2011 Lancet paper describing an allegedly groundbreaking procedure to transplant an artificial trachea seeded with stem cells is objecting to a recent investigation that concluded Macchiarini had committed misconduct. Ola Hermanson, who studies neural stem cells at Karolinska Institutet, argued in a report dated June 29 that the … Continue reading Macchiarini co-author objects to investigation’s misconduct verdict

Weekend reads: Turning journal spam into a paper; embracing science’s flaws; ending bias

This week at Retraction Watch featured the retraction of a Cell paper by Harvard researchers and the retraction of a JCI study by NIH scientists. Here’s what was happening elsewhere: